TY - JOUR T1 - Is gestational diabetes a risk factor for neonatal hearing loss? TT - Gestasyonel diyabet yenidoğan işitme kaybında bir risk faktörü müdür? AU - Hanege, Fatih Mehmet AU - Yılmaz Hanege, Burcu AU - Çelik, Serdal AU - Göçmen, Ahmet AU - Kalcıoğlu, M.tayyar PY - 2019 DA - March DO - 10.25000/acem.491222 JF - Archives of Clinical and Experimental Medicine JO - Arch Clin Exp Med PB - Mustafa HASBAHÇECİ WT - DergiPark SN - 2564-6567 SP - 29 EP - 32 VL - 4 IS - 1 LA - en AB - Aim: Newborn hearing screening is important for earlydetection of hearing loss in newborns. Gestational diabetes is a metabolicdisease that can occur in pregnancy and cause complications such as those in theother diabetes mellitus patients. As uncomplicated gestational diabetes has notbeen described as a cause for prenatal complications in the literature, thisstudy aimed to determine whether gestational diabetes is a risk factor forhearing impairment among newborns.Methods: This retrospective study includedinfants born between 2015 and 2017. The infants were divided into two groups: Controlgroup consisted of 100 randomly selected children of healthy mothers. Studygroup consisted of 79 infants whose mothers had gestational diabetes mellitus. Exclusioncriteria included other risk factors and 8 infants were excluded from the studydue to risk factors other than gestational diabetes mellitus. The results oftransient evoked otoacoustic emissions in infants of mothers with gestationaldiabetes were compared with those of infants of healthy mothers.Results: In this study,we compared transient evoked otoacoustic emission results of 71 infants of gestationaldiabetic mothers with 100 infants of healthy mothers. All the infants ofhealthy mothers, as well as the infants of mothers with gestational diabeteswithout risk factors, passed the transient evoked otoacoustic emission test.Conclusions: There was nodifference detected in the hearing screening results between infants of motherswith gestational diabetes and infants of healthy mothers. KW - Gestational diabetes KW - neonatal hearing loss KW - hearing screening KW - otoacoustic emission N2 - Amaç: İşitme kaybı,yenidoğanlar arasında en sık görülen konjenital anomalilerden biridir.Yenidoğan işitme tarama programı işitme kaybı olan yenidoğanlarda erken tanıiçin önem arz etmektedir Gestasyonel diyabet ise gebelikte ortaya çıkan vediğer diyabetes mellitus tanısı alan hastalardaki gibi komplikasyonlara nedenolabilen metabolik bir hastalıktır. Komplike olmamış gestasyonel diyabetiişitme kaybı riski oluşturan prenatal bir komplikasyon olarak tanımlayan birçalışma literatürde bulunmamaktadır. Bu çalışmada gestasyonel diyabetinyenidoğanlarda işitme bozukluğu için bir risk faktörü olup olmadığınıbelirlemeyi amaçladık.Metod: Buretrospektif çalışmaya 2015-2017 yılları arasında doğan bebekler dahil edildi.Bebekler iki gruba ayrıldı; Kontrol grubu: Rastgele seçilen sağlıklı 100annenin çocuğundan oluşuyordu. Çalışma grubu: 8 tanesi en az bir risk faktörünesahip olup çalışma dışında bırakılan, gestasyonel diyabeti olan annelerdendoğan 79 bebekten oluşan grup idi. Gestasyonel diyabeti olan annelerden doğanbebeklerin transient otoakustik emisyon sonuçlarının sağlıklı annelerdendoğanların sonuçları ile karşılaştırdık.Bulgular: Bu çalışmada 71 gestasyonel diyabeti olananne bebeği ile 100 sağlıklı anne bebeğinin transient otoakustik emisyonsonuçları ile karşılaştırıldı. Sağlıklı annelerin bebeklerinin yanı sıra risk faktörüolmayan gestasyonel diyabeti olan anne bebeklerinin tümü transient otoakustikemisyon testini geçti. Sonuç: Annesindegestasyonel diyabeti olan bebeklerin işitme tarama sonuçları ile annesisağlıklı olan bebeklerin işitme tarama sonuçları arasında bir fark tespit edilememiştir. CR - 1. Turchetta R, Conti G, Marsella P, Orlando MP, Picciotti PM, Frezza S, et al. Universal newborn hearing screening in the Lazio region, Italy. Ital J Pediatr. 2018;44:104. CR - 2. Committee on Fetus and Newborn. Joint statement on neonatal screening for hearing impairment.Pediatrics. 1971;47:1085. CR - 3. Kemp DT. Stimulated acoustic emissions from within the human auditory system. J Acoust Soc Am. 1978;64:1386-91. CR - 4. National Institutes of Health Consensus Development Conference Statement. Early identification of hearing impairment in infants and young children. Int J Pediatr Otorhinolaryngol. 1993;27:215-27. CR - 5. Wood SA, Sutton GJ, Davis AC. Performance and characteristics of the Newborn Hearing Screening Programme in England: The first seven years. Int J Audiol. 2015;54:353-8. CR - 6. Chung W, Beauchaine KL, Grimes A, O'Hollearn T, Mason C, Ringwalt S. Reporting Newborn Audiologic Results to State EHDI Programs. Ear Hear. 2017;38:638-42. CR - 7. Grandori F. European Consensus Statement on Neonatal Hearing Screening. J Laryngol Otol. 1998;112:1219., CR - 8. Kemaloglu YK, Gokdogan C, Gunduz B, Onal EE, Turkyilmaz C, Atalay Y. Newborn Newborn hearing screening outcomes during the first decade of the program in a reference hospital from Turkey. Eur Arch Otorhinolaryngol. 2016;273:1143-49. CR - 9. Jakubíková J, Kabátová Z, Pavlovcinová G, Profant M. Newborn hearing screening and strategy for early detection of hearing loss in infants. Int J Pediatr Otorhinolaryngol. 2009;73:607-12. CR - 10. Arslan S, Işik AU, Imamoglu M, Topbas M, Aslan Y, Ural A. Universal newborn hearing screening; automated transient evoked otoacoustic emissions. B-ENT. 2013;9:122-31. CR - 11. Meyer C, Witte J, Hildmann A , Hennecke KH, Schunck KU, Maul K. Neonatal screening for hearing disorders in infants at risk: incidence, risk factors, and follow-up. Pediatrics. 1999;104:900-4. CR - 12. Selcuk A, Terzi H, Turkay U, Kale A, Genc S. Does gestational diabetes result in cochlear damage? J Laryngol Otol. 2014;128:961-5. CR - 13. Woolf NK, Harris JP. Cochlear pathophysiology associated with inner ear immune responses. Acta Otolaryngol. 1986;102:353-64. CR - 14. Hanege BY, Hanege FM, Kalcioglu MT, Gocmen A. Is maternal preeclampsia risk factor for neonatal hearing loss? B-ENT. 2017;13:219-23. CR - 15. Ewart-Toland A, Yankowitz J, Winder A, Imagire R, Cox VA, Aylsworth AS. Oculoauriculovertebral abnormalities in children of diabetic mothers. Am J Med Genet. 2000;90:303-9. CR - 16. Gratz ES, Pollack MA, Zimmerman RD. Congenital facial palsy and ipsilateral deafness: association with maternal diabetes mellitus. Int J Pediatr Otorhinolaryngol. 1981;3:335-41. CR - 17. Kelemen G. Aural changes in the embryo of diabetic mother. AMA Arch Otolaryngol. 1955;62:357-69. CR - 18. Sudasinghe BH, Wijeyaratne CN, Ginige PS. Long and short-term outcomes of Gestational Diabetes Mellitus (GDM) among South Asian women - A community-based study. Diabetes Res Clin Pract. 2018;145:93-101. CR - 19. Schwartz R, Teramo KA. Effects of diabetic pregnancy on the fetus and newborn. Semin Perinatol. 2000;24:120-35. CR - 20. Weintrob N, Karp M, Hod M. Short- and long-range complications in offspring of diabetic mothers. J Diabetes Complications. 1996;10:294-301. UR - https://doi.org/10.25000/acem.491222 L1 - https://dergipark.org.tr/en/download/article-file/671634 ER -